Employees Retirement System Of Texas Supernus Pharmaceuticals, Inc. Transaction History

Employees Retirement System Of Texas

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 12, 2019	SELL	$25.47 - $33.37 $356,580 - $467,179	-14,000 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$29.96 - $38.87 $209,720 - $272,090	-7,000 Reduced 33.33%	14,000 $463,000
Q2 2018 Aug 10, 2018	SELL	$44.1 - $59.85 $176,400 - $239,400	-4,000 Reduced 16.0%	21,000 $1.26 Million
Q1 2018 May 11, 2018	SELL	$37.15 - $46.9 $557,250 - $703,500	-15,000 Reduced 37.5%	25,000 $1.15 Million
Q4 2017 Feb 09, 2018	SELL	$36.4 - $42.6 $291,200 - $340,800	-8,000 Reduced 16.67%	40,000 $1.59 Million

Q3 2017 Nov 13, 2017	BUY	$36.75 - $49.65 $477,750 - $645,450	13,000 Added 37.14%	48,000 $1.92 Million
Q2 2017 Aug 14, 2017	BUY	N/A	35,000	35,000 $1.51 Million

260

57.3M

84.1K

61.2K

Ticker SUPN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,495,300
Market Cap $1.39B
Description
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...

Get notified when there are updates to the investment portfolio of Employees Retirement System Of Texas, based on Form 13F filings with the SEC.

Stay updated on Employees Retirement System Of Texas with notifications on news.